PDL BioPharma, Inc.
(NASDAQ:PDLI)|
9.25 -0.33 (-3.44%) 3:14ET Delayed |
|
|
|
- Compare PDLI with:
- View: Line | Candlestick
Company Profile
PDL BioPharma, Inc.
1400 Seaport Boulevard
Redwood City, CA 94063
United States - Map
Phone: (650) 454-1000
Fax: (650) 454-2000
Website: www.pdl.com
State of incorporation: Delaware
CEO: Faheem Hasnain
Employees: 887
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Des antibodies/proteins for disease treatment
A biopharmaceutical company focused on the discovery and development of novel antibodies in oncology and immunologic diseases.
Recent news for PDLI
-
Don't Make a Million-Dollar Mistake
Motley Fool - Nov 22 at 8:00 ET
-
PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online - Nov 20 at 1:27 ET
-
Value Guru Klarman Seeks Out Opportunities in Down Market
Indie Research - Nov 20 at 9:36 ET
-
PDL hopes to spin off biotech unit by Dec. 18
bizjournals.com - Nov 20 at 7:05 ET
-
PDL BioPharma Announces Record Date for Spin-Off of Biotechnology Operations
Marketwire - Nov 19 at 9:06 ET
-
PDL BIOPHARMA, INC. Financials
EDGAR Online Financials - Nov 15 at 9:04 ET
-
EDGAR Online - Nov 12 at 4:19 ET
-
TheStreet.com - Nov 11 at 5:38 ET
-
PDL names McLaughlin as CEO-to-be
bizjournals.com - Nov 11 at 4:05 ET
-
EDGAR Online - Nov 10 at 4:20 ET
